---
title: "Aqua Bio Technology Calls Extraordinary Meeting to Approve Reverse Split and Capital Measures"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/273712926.md"
description: "Aqua Bio Technology ASA has announced an extraordinary general meeting on February 16, 2026, in Oslo to seek shareholder approval for a 50-for-1 reverse share split and various capital measures. The agenda includes a share capital increase, broader authorization for future capital raises, updates to executive remuneration guidelines, and share issuance related to an option program, indicating active balance-sheet management and potential financing for growth. Aqua Bio Technology ASA focuses on skincare and biotechnology ingredients and is listed on Euronext Expand in Oslo."
datetime: "2026-01-26T14:03:42.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/273712926.md)
  - [en](https://longbridge.com/en/news/273712926.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/273712926.md)
---

# Aqua Bio Technology Calls Extraordinary Meeting to Approve Reverse Split and Capital Measures

### Claim 50% Off TipRanks Premium

-   Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
-   Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential

Aqua Bio Technology ASA ( (DE:3FZ) ) has provided an announcement.

Aqua Bio Technology ASA has called an extraordinary general meeting for 16 February 2026 in Oslo to seek shareholder approval for a 50-for-1 reverse share split and several measures to strengthen its capital structure. The agenda also includes approving a specific share capital increase, granting a broader authorization for future capital raises, updating executive remuneration guidelines, and authorizing share issuance related to an option program, moves that collectively signal active balance-sheet management and potential future financing to support the company’s operations and growth plans.

**More about Aqua Bio Technology ASA**

Aqua Bio Technology ASA (ABTEC) is a Norway-based technology and distribution group focused on skincare and other non-food products. The company serves both B2C and B2B markets, offering distribution, freight, customs clearance and logistics services, and it develops sustainable biotechnology ingredients for use in skincare formulations. Aqua Bio Technology is listed on Euronext Expand in Oslo.

**YTD Price Performance:** -47.60%

**Average Trading Volume:** 332,148

**Current Market Cap:** NOK38.73M

For a thorough assessment of 3FZ stock, go to TipRanks’ Stock Analysis page.

### Related Stocks

- [AQB.US](https://longbridge.com/en/quote/AQB.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [08:00 ETAvance Clinical Receives Frost & Sullivan's 2026 Global Company of the Year Recognition for Excellence in Biotech CRO Leadership](https://longbridge.com/en/news/286094661.md)
- [How Does Nuvation Bio’s (NUVB) IBTROZI Update Reframe Its Long-Term Oncology Investment Narrative?](https://longbridge.com/en/news/287097726.md)
- [Activist Elliott Takes Major Stake in Bio-Rad — Can It Boost BIO Stock Price?](https://longbridge.com/en/news/286737807.md)
- [Kyntra Bio Rocked by CEO’s Sudden Insider Stock Sale](https://longbridge.com/en/news/286847501.md)
- [08:23 ETScientific Longevity Company Immorta Bio Appoints Former Ernst & Young Health Sciences Partner Howard Brooks to Corporate Board of Directors](https://longbridge.com/en/news/287219677.md)